Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.
Cancer Biother Radiopharm
; 27(1): 41-55, 2012 Feb.
Article
in En
| MEDLINE
| ID: mdl-22191802
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Epirubicin
/
Receptor, ErbB-2
/
Antibiotics, Antineoplastic
Limits:
Female
/
Humans
Language:
En
Journal:
Cancer Biother Radiopharm
Journal subject:
FARMACIA
/
FARMACOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United States